5058 POSTER Randomized Phase II Multicenter Trial of Oral Antiangiogenic Agent TSU-68 in Combination With Docetaxel Versus Docetaxel Alone in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline
Authors:
- S. KimSKS. Kim
- J.H. AhnJAJ.H. Ahn
- J. RoJRJ. Ro
- S.A. ImSIS.A. Im
- Y.H. ImYIY.H. Im
- J.H. KimJKJ.H. Kim
- H.S. SongHSH.S. Song
- S.Y. KangSKS.Y. Kang
- H.S. ParkHPH.S. Park
- H.C. ChungHCH.C. Chung
- 30 September 2011
- journal article
- abstracts
- Published by Elsevier in European Journal of Cancer
- Vol. 47, S347